SPRAVATO DIN 02499290
Health Canada record
| Active ingredient(s) | ESKETAMINE (ESKETAMINE HYDROCHLORIDE) 28 MG |
|---|---|
| Dosage form | Solution |
| Route | Nasal |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N06AX27 ESKETAMINE |
| Original market date | 11-Jun-2020 |
| Current status date | 11-Jun-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23645 | 2020-05-20 | New Drug Submission (NDS) |